Heranba Industries Limited has announced a board meeting scheduled for Monday, April 27, 2026, to deliberate on significant corporate restructuring matters. The meeting has been convened in compliance with Regulation 29 and 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Board Meeting Agenda

The primary focus of the upcoming board meeting centers on a strategic financial restructuring proposal involving the company's subsidiary operations. The board will consider and approve the conversion of Inter-Corporate Deposits (ICD) previously granted by the company to its wholly owned subsidiary, Heranba Organics Private Limited (HOPL).

Financial Instrument Conversion

The proposed conversion involves transforming existing Inter-Corporate Deposits into Optionally Fully Convertible Debentures (OFCDs). This restructuring will be executed on terms and conditions that receive board approval during the scheduled meeting. The conversion represents a strategic move to optimize the financial structure between the parent company and its wholly owned subsidiary.

Trading Window Restrictions

Heranba Industries has informed stakeholders about existing trading window restrictions that affect company securities. The trading window closure commenced on April 01, 2026, and will remain in effect until 48 hours after the declaration of financial results for the quarter and year ended March 31, 2026.

Regulatory Compliance

The company's announcement demonstrates adherence to multiple regulatory frameworks governing listed entities. The board meeting intimation fulfills requirements under SEBI's Listing Obligations and Disclosure Requirements Regulations, while the trading window restrictions align with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015.

The company has also referenced its internal Code of Conduct for regulating, monitoring and reporting of trading by insiders, along with its Code of fair disclosure of unpublished price sensitive information. These measures ensure comprehensive compliance with regulatory standards governing corporate governance and market transparency.

Heranba Industries Limited has launched two innovative crop nutrition products, Fentaamine and MycoHil, marking its strategic entry into the rapidly expanding crop nutrition segment. The company announced ambitious revenue targets of ₹2,500 crore for the current fiscal year from its combined crop protection and crop nutrition segments.

Product Launch Details

The company introduced these breakthrough products at a grand launch event held at Leonia Holistic Destination in Hyderabad. Both products fall under the category of innovative crop nutrition solutions and are initially targeted at the domestic market.

Product Specifications and Benefits

Fentaamine is positioned as a next-generation bio stimulant engineered to enhance plant metabolism, improve stress tolerance, and boost crop yield. The product focuses on optimizing plant physiological processes to deliver improved agricultural outcomes.

MycoHil serves as an advanced biofertilizer designed to improve nutrient absorption, strengthen soil microbiology, and promote sustainable agriculture practices. This product emphasizes soil health enhancement and sustainable farming methodologies.

Both products have been developed through collaboration with a leading American multinational company, combining global research expertise with Heranba Industries' robust manufacturing capabilities.

Strategic Vision and Growth Targets

The company's entry into crop nutrition aligns with its Vision 2026 growth roadmap. Managing Director R. K. Shetty highlighted that the crop nutrition segment is witnessing strong growth with a CAGR of over 15% globally and in India, making it a natural strategic progression for the company.

Capability Enhancement Initiatives

To support its expansion strategy, Heranba Industries Limited is investing in multiple areas including talent acquisition and capability building, strengthening sales and marketing infrastructure, enhancing last-mile farmer engagement, channel partners engagement, and expanding global business operations.

The company operates as a leading manufacturer of synthetic pyrethroids and intermediates with a strong presence across the agrochemical value chain, from technicals to formulations. This latest product launch represents a significant milestone in the company's commitment to improving crop productivity and supporting global food security through innovative agricultural solutions.